Olubunmi Oduwole

Olubunmi Oduwole has extensive experience in the field of clinical research and project management. From 2022 to the present, they have held the role of Associate Director of Clinical Operations at Silence Therapeutics plc. Prior to that, they worked at ICON Clinical Research (U.K.) Limited from 2013 to 2022 as a Senior Project Manager, where they were responsible for overseeing and delivering complex projects and programs in clinical operations.

Before joining ICON, Olubunmi worked at Eli Lilly and Company from 2004 to 2013. During this time, they held the positions of Clinical Trial Management Program Manager and Clinical Trial Manager, where they managed the coordination and execution of clinical trials, ensuring quality, cost, and timely delivery.

Olubunmi's earlier experience includes roles at Quintiles, Covance, and PPD, where they held positions such as Clinical Team Leader and Clinical Research Scientist. These roles involved leading cross-functional teams and conducting clinical research activities.

Overall, Olubunmi Oduwole has a strong background in clinical research, project management, and operational strategy, with experience working in both global and regional settings.

From 1990 to 1994, Olubunmi Oduwole attended The University of Salford, where they obtained a Bachelor of Science degree in Applied Chemistry.